Tumor Suppressors Status in Cancer Cell Line Encyclopedia

被引:22
|
作者
Sonkin, Dmitriy [1 ]
Hassan, Mehedi [1 ]
Murphy, Denis J. [1 ]
Tatarinova, Tatiana V. [1 ,2 ]
机构
[1] Univ South Wales, Pontypridd CF37 1DL, M Glam, Wales
[2] Univ So Calif, Lab Appl Pharmacokinet, Los Angeles, CA 90089 USA
关键词
Tumor suppressor; Cancer cell line; CCLE; Loss of function; DNA methylation; Epigenetics; DATABASE; GENE; MDM2; MUTATION; PATHWAY; SAMPLES; TP53;
D O I
10.1016/j.molonc.2013.04.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor suppressors play a major role in the etiology of human cancer, and typically achieve a tumor-promoting effect upon complete functional inactivation. Bi-allelic inactivation of tumor suppressors may occur through genetic mechanisms (such as loss of function mutation, copy number (CN) loss, or loss of heterozygosity (LOH)), epigenetic mechanisms (such as promoter methylation or histone modification), or a combination of the two. We report systematically derived status of 69 known or putative tumor suppressors, across 799 samples of the Cancer Cell Line Encyclopedia. In order to generate such resource we constructed a novel comprehensive computational framework for the assessment of tumor suppressor functional "status". This approach utilizes several orthogonal genomic data types, including mutation data, copy number, LOH and expression. Through correlation with additional data types (compound sensitivity and gene set activity) we show that this integrative method provides a more accurate assessment of tumor suppressor status than can be inferred by expression, copy number, or mutation alone. This approach has the potential for a more realistic assessment of tumor suppressor genes for both basic and translational oncology research. (C) 2013 Federation. of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:791 / 798
页数:8
相关论文
共 50 条
  • [21] Microtubule-associated tumor suppressors as prognostic biomarkers in breast cancer
    Sylvie Rodrigues-Ferreira
    Angie Molina
    Clara Nahmias
    Breast Cancer Research and Treatment, 2020, 179 : 267 - 273
  • [22] Application of iPS cell technology to cancer epigenome study: Uncovering the mechanism of cell status conversion for drug resistance in tumor
    Matsuda, Yutaka
    Semi, Katsunori
    Yamada, Yasuhiro
    PATHOLOGY INTERNATIONAL, 2014, 64 (07) : 299 - 308
  • [23] microRNAs as oncogenes and tumor suppressors
    Zhang, Baohong
    Pan, Xiaoping
    Cobb, George P.
    Anderson, Todd A.
    DEVELOPMENTAL BIOLOGY, 2007, 302 (01) : 1 - 12
  • [24] MicroRNAs function as tumor suppressors or oncogenes: Aberrant expression of microRNAs in head and neck squamous cell carcinoma
    Nohata, Nijiro
    Hanazawa, Toyoyuki
    Kinoshita, Takashi
    Okamoto, Yoshitaka
    Seki, Naohiko
    AURIS NASUS LARYNX, 2013, 40 (02) : 143 - 149
  • [25] Tumor suppressors in follicular lymphoma
    Graham, Cassandra
    LeBrun, David P.
    LEUKEMIA & LYMPHOMA, 2015, 56 (07) : 1981 - 1988
  • [26] In vitro chemosensitivity of a canine tumor venereal transmissible cancer cell line
    Franco Molina, Moises Armides
    Antonio Santamaria-Martinez, Edson
    Santana Krimskaya, Silvia Elena
    Ginette Zarate-Trivino, Diana
    Kawas, Jorge R.
    Ramos Zayas, Yareellys
    Palacios Estrada, Natanael
    Prado Garcia, Heriberto
    Garcia Coronado, Paola Leonor
    Rodriguez Padilla, Cristina
    FRONTIERS IN VETERINARY SCIENCE, 2022, 9
  • [27] Ten-eleven translocation proteins (TETs): tumor suppressors or tumor enhancers?
    Ma, Cuili
    Seong, Hwanwook
    Liu, Yumei
    Yu, Xiao
    Xu, Shuanliang
    Li, Yujing
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2021, 26 (10): : 895 - 915
  • [28] The ARF tumor suppressor: structure, functions and status in cancer
    Ozenne, Peggy
    Eymin, Beatrice
    Brambilla, Elisabeth
    Gazzeri, Sylvie
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (10) : 2239 - 2247
  • [29] Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma
    Gailhouste, Luc
    Ochiya, Takahiro
    HISTOLOGY AND HISTOPATHOLOGY, 2013, 28 (04) : 437 - 451
  • [30] The structural impact of cancer-associated missense mutations in oncogenes and tumor suppressors
    Stehr, Henning
    Jang, Seon-Hi J.
    Duarte, Jose M.
    Wierling, Christoph
    Lehrach, Hans
    Lappe, Michael
    Lange, Bodo M. H.
    MOLECULAR CANCER, 2011, 10